Veridia Medical Center has been operating on the private medical services market for 17 years. It started its activity with a medical analysis laboratory and later consolidated its position by developing a large medical center that incorporates 20 offices and which provides specialized medical services, general medicine consultations and consultations of different specialties, paraclinical investigations, treatments and minor surgeries. Additionally, for blood sampling for laboratory testing, the medical center includes four sampling points, located in the Bucharest neighborhoods of Berceni, Militari, Drumul Taberei and Pantelimon.
Since the beginning of September this year, Veridia Medical Center, through the molecular biology laboratory, has partenered with the Public Health Directorate (DSP) for RT-PCR testing designed to detect the SARS-CoV-2 virus, with a capacity of 400 samples per day.
“The decision to introduce a company like Veridia in the group is a good one, especially in the context in which we are talking about a medical services company that has adapted very well to the context, came to the support of the state through COVID testing and offered patients screening services that meet the current needs,” said Mihai Marcu, President and CEO of MedLife Group.
Veridia is one of the relevant providers of medical services under contract with the Health Insurance House of Bucharest, covering over 25 specialties, including allergology, ENT, endocrinology, obstetrics-gynecology, pediatrics, cardiology, pneumology, gastroenterology and neurology. For the corporate segment, the medical center plays an important role, as it also provides companies with occupational health services.
Through the acquisition of Veridia Medical Center, MedLife group reaches a portfolio of 27 acquired companies, the last announced being Micromedica Medical Center.
“We have other acquisitions planned and we will announce them as we move forward with them,” added Marcu.